Pharmacovigilance Outsourcing Market Analysis, Size, Trends, and Forecast by 2031

Historic Data: 2021-2023   |   Base Year: 2024   |   Forecast Period: 2025-2031

Pharmacovigilance Outsourcing Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage : by Type (Adverse Drug Reaction Capture, Case Processing, Reporting and Submission, Report Publishing, Quality Check, Risk Management, Knowledge Management); End User (Pharmaceutical Industry, Research Organization); and Geography (North America, Europe, Asia Pacific, and South and Central America)

  • Report Date : Oct 2025
  • Report Code : TIPRE00040657
  • Category : Life Sciences
  • Status : Upcoming
  • Available Report Formats : pdf-format excel-format
  • No. of Pages : 150
Page Updated: Mar 2025

AI overview of Pharmacovigilance Outsourcing Market


The Pharmacovigilance Outsourcing Market is poised for significant growth, with a projected market size reaching US$ XX million by 2031, reflecting a robust CAGR of 16.1% from 2025 to 2031. This growth is driven by increasing regulatory demands and the need for cost-effectiveness within the pharmaceutical industry. Key segments include adverse drug reaction capture and risk management, catering to both pharmaceutical companies and research organizations. Notably, the market is witnessing a trend towards the adoption of advanced technologies and data analytics, enhancing global compliance efforts. As companies focus on core competencies, opportunities in emerging markets and strategic partnerships for innovation are expected to shape the future landscape of the Pharmacovigilance Outsourcing Market.


The Pharmacovigilance Outsourcing Market is expected to register a CAGR of 16.1% from 2025 to 2031, with a market size expanding from US$ XX million in 2024 to US$ XX Million by 2031.

The report is segmented By Type (Adverse Drug Reaction Capture (ADR), Case Processing, Reporting and Submission, Report Publishing, Quality Check, Risk Management, Knowledge Management, Others); End User (Pharmaceutical Industry, Research Organization, Others) . The global analysis is further broken-down at regional level and major countries. The Report Offers the Value in USD for the above analysis and segments.

Purpose of the Report

The report Pharmacovigilance Outsourcing Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:

  • Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
  • Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
  • Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.

Pharmacovigilance Outsourcing Market Segmentation

Type

  • Adverse Drug Reaction Capture
  • Case Processing
  • Reporting and Submission
  • Report Publishing
  • Quality Check
  • Risk Management
  • Knowledge Management

End User

  • Pharmaceutical Industry
  • Research Organization

Customize This Report To Suit Your Requirement

You will get customization on any report - free of charge - including parts of this report, or country-level analysis, Excel Data pack, as well as avail great offers and discounts for start-ups & universities

Pharmacovigilance Outsourcing Market: Strategic Insights

pharmacovigilance-outsourcing-market
  • Get Top Key Market Trends of this report.
    This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

Pharmacovigilance Outsourcing Market Growth Drivers

  • Increased Regulatory Demands: Increased complexity and retention of regulatory requirements for the monitoring of drug safety have been strong drivers for the outsourcing of pharmacovigilance. Regulatory conditions set by regulatory agencies place extremely strict guidelines on pharmaceutical manufacturers with regard to safety reporting and risk-management systems. This makes available highly specialized skills and resources for organizations to leverage while concentrating on their core business functions to get in tune with the triggered market demand through pharmacovigilance outsourcing.
  • Cost Effectivity and Productivity: Pharmaceutical companies are looking to strict outsourcing as a portends for improving cost efficiency and productivity. It may well be in giving organizations the chance to pool specialized service providers' resources while avoiding the hefty costs associated with maintaining the internal teams and their infrastructure. Additionally, because outsourced systems move organizations to advanced technology and staff experienced in delivering much faster safety data analysis and reporting, this can lead to better resource allocation and an uptick in productivity.
  • Normally Concentrating on Core Competencies: Outsourcing of pharmacovigilance is most beneficial for pharmacy companies whose focus is primarily on their core competence, such as drug development and marketing, because it enables them to leave the task of monitoring their drug's safety to outsourced external facilities while having all their internal organizations shape into regions of novelty and growth, knowing that their safety monitoring will involve professionals who are known to be experts in this field. It is therefore a strategic decision for business performance and overall competitiveness of the market

Pharmacovigilance Outsourcing Market Future Trends

  • Adoption of Advanced Technologies: The increased automation and information technology within the field of pharmacovigilance is now taking the common step of artificial intelligence and machine learning. These leads the safety monitoring process out of a work which constitutes speeding up data collection, signal detection, and risk assessment. Companies now can provide better insight for decision making, minimize manual load, and keep all work into compliance with the swiftly changing regulatory requirements as such technologies come into their outsourced
  • Data Analytics: Further innovation in regarding data analytics is taking place with the pharmacovigilance outsourcing market. Sophisticated data analysis tools, however, have been turned to by the companies to give better insights on huge safety data volumes. With this segmentation i.e. discovery of so-called safety signals at a much earlier stage, it becomes clearer as it assists with risk manager strategies and enables timely submission period for regulatory submissions and, beyond improving patient safety, could strengthen pharmacovigilance practices.
  • Increased Focus on Global Compliance: The more the pharmaceutical industry becomes globalized, the more stringent will compliance with different regulatory requirements in different regions be. This encourages the seeking of pharmacovigilance outsourcing services that would help avoid international bureaucracies in whatever country in opening market access. Global outsourcing partners bequeath a good degree in ease and offer adequate assistance in overcoming compliance challenges so that pharmaceutical companies broaden their arms but keep safety standards

Pharmacovigilance Outsourcing Market Opportunities

  • Emerging Markets Expansion: The established pharmacovigilance outsourcing market has lots of room and opportunities for expansions in the emerging markets. There are fast advancements in the pharmaceutical industries and their changing regulatory systems, which require more thoroughly developed harmonized safety monitoring systems. Local expertise and resources by outsourcing partners would help navigate compliance challenges while tapping into some new markets savings of investments on the global footprint.
  • Install Strategic Partnerships for Innovation: The strategic coupling of a pharmaceutical company with a specialized pharmacovigilance service provider becomes a fruitful opportunity for innovation. Says it illustrates that by collaboration, organizations could leverage advanced technologies to provide appropriate solutions for safety monitoring through AI and big data analytics. Thus, continuous cost-effective operations and investments made by both organizations would also lead to innovations in tool and methodology development and thus increased outsourcing market growth.
  • Pay Attention to Patient-Centric Approach: The fact that healthcare will increasingly focus more on patient-centered approaches will yield an exciting opportunity for the pharmacovigilance outsourcing market. The result in terms of enhancing the capabilities of companies for patient safety and experience would be gained through effective outsourcing of their pharmacovigilance activities. Service providers would organize better communication strategies, interactions with patient populations, and acquisition of real-world safety data, leading improved safety profiles and stronger relationships with the regulators.

Pharmacovigilance Outsourcing Market Regional Insights

The regional trends and factors influencing the Pharmacovigilance Outsourcing Market throughout the forecast period have been thoroughly explained by the analysts at The Insight Partners. This section also discusses Pharmacovigilance Outsourcing Market segments and geography across North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America.

Pharmacovigilance Outsourcing Market Report Scope

Report Attribute Details
Market size in 2024 US$ XX million
Market Size by 2031 US$ XX Million
Global CAGR (2025 - 2031) 16.1%
Historical Data 2021-2023
Forecast period 2025-2031
Segments Covered By Type
  • Adverse Drug Reaction Capture
  • Case Processing
  • Reporting and Submission
  • Report Publishing
  • Quality Check
  • Risk Management
  • Knowledge Management
By End User
  • Pharmaceutical Industry
  • Research Organization
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Labcorp Drug Development
  • Icon Plc
  • Cognizant Technology Solutions
  • Corporation
  • Ergomed Plc.
  • Capgemini
  • Genpact Limited
  • Accenture Plc.
  • Iqvia Holdings Inc.
  • International Business Machines Corporation

  • Pharmacovigilance Outsourcing Market Players Density: Understanding Its Impact on Business Dynamics

    The Pharmacovigilance Outsourcing Market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.


    pharmacovigilance-outsourcing-market-cagr

    • Get the Pharmacovigilance Outsourcing Market top key players overview

    Key Selling Points

    • Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the Pharmacovigilance Outsourcing Market, providing a holistic landscape.
    • Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
    • Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
    • Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.

    The research report on the Pharmacovigilance Outsourcing Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.


    Frequently Asked Questions

    1
    Who are the prominent players in Pharmacovigilance Outsourcing Market?
    Cognizant Technology Solutions Corporation, Ergomed Plc., Capgemini, Genpact Limited, Accenture Plc. the major companies operating in the Pharmacovigilance Outsourcing Market?
    2
    Which is the fastest growing region in Pharmacovigilance Outsourcing Market?
    Asia Pacific is estimated to grow at the highest CAGR over the forecast year (2025 - 2031)
    3
    Which region accounts for highest revenue share Pharmacovigilance Outsourcing Market?
    The North America region accounts for highest revenue share Pharmacovigilance Outsourcing Market?
    4
    What years does this Pharmacovigilance Outsourcing Market?
    The final report will duly include market size and projection estimates for all the segments from 2021 to 2031, along with a revenue share and compound annual growth rate (%) for the regional
    /
    country-wise market wherein 2021-2023 are the historic years, 2024 is considered to be the base year, and the forecast will be provided till 2031, along with CAGR (%)
    5
    At what CAGR the Pharmacovigilance Outsourcing Market projected to grow?
    The market is expected to grow at a CAGR of 16.1%
    6
    Major driver boosting the Pharmacovigilance Outsourcing Market growth?
    Increased Regulatory Demands is the major factors boosting the Pharmacovigilance Outsourcing Market growth
    Mrinal Kerhalkar
    Manager,
    Market Research & Consulting

    Mrinal is a seasoned research analyst with over 8 years of experience in Life Sciences Market Intelligence and Consulting. With a strategic mindset and unwavering commitment to excellence, she has built deep expertise in pharmaceutical forecasting, market opportunity assessment, and developing industry benchmarks. Her work is anchored in delivering actionable insights that empower clients to make informed strategic decisions.

    Mrinal’s core strength lies in translating complex quantitative datasets into meaningful business intelligence. Her analytical acumen is instrumental in shaping go-to-market (GTM) strategies and uncovering growth opportunities across the pharmaceutical and medical device sectors. As a trusted consultant, she consistently focuses on streamlining workflow processes and establishing best practices, thereby driving innovation and operational efficiency for her clients.

    • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
    • PEST and SWOT Analysis
    • Market Size Value / Volume - Global, Regional, Country
    • Industry and Competitive Landscape
    • Excel Dataset

    Testimonials

    Reason to Buy

    • Informed Decision-Making
    • Understanding Market Dynamics
    • Competitive Analysis
    • Identifying Emerging Markets
    • Customer Insights
    • Market Forecasts
    • Risk Mitigation
    • Boosting Operational Efficiency
    • Strategic Planning
    • Investment Justification
    • Tracking Industry Innovations
    • Aligning with Regulatory Trends
    Your Key Concerns Addressed - Question & Answer
    Can I view a sample of the report before purchasing?

    Yes! We provide a free sample of the report, which includes Report Scope (Table of Contents), report structure, and selected insights to help you assess the value of the full report. Please click on the "Download Sample" button or contact us to receive your copy.

    Is analyst support included with the purchase?

    Absolutely — analyst assistance is part of the package. You can connect with our analyst post-purchase to clarify report insights, methodology or discuss how the findings apply to your business needs.

    What are the next steps once I place an order?

    Once your order is successfully placed, you will receive a confirmation email along with your invoice.

    • For published reports: You’ll receive access to the report within 4–6 working hours via a secured email sent to your email.
    • For upcoming reports: Your order will be recorded as a pre-booking. Our team will share the estimated release date and keep you informed of any updates. As soon as the report is published, it will be delivered to your registered email.

    Can the report be tailored to suit my specific needs?

    We offer customization options to align the report with your specific objectives. Whether you need deeper insights into a particular region, industry segment, competitor analysis, or data cut, our research team can tailor the report accordingly. Please share your requirements with us, and we’ll be happy to provide a customized proposal or scope.

    In what format is the report delivered?

    The report is available in either PDF format or as an Excel dataset, depending on the license you choose.

    The PDF version provides the full analysis and visuals in a ready-to-read format. The Excel dataset includes all underlying data tables for easy manipulation and further analysis.
    Please review the license options at checkout or contact us to confirm which formats are included with your purchase.

    How secure is the payment process on your platform?

    Our payment process is fully secure and PCI-DSS compliant.

    We use trusted and encrypted payment gateways to ensure that all transactions are protected with industry-standard SSL encryption. Your payment details are never stored on our servers and are handled securely by certified third-party processors.
    You can make your purchase with confidence, knowing your personal and financial information is safe with us.

    Do you provide special pricing for buying multiple reports?

    Yes, we do offer special pricing for bulk purchases.
    If you're interested in purchasing multiple reports, we’re happy to provide a customized bundle offer or volume-based discount tailored to your needs. Please contact our sales team with the list of reports you’re considering, and we’ll share a personalized quote.

    Can I connect with your team to discuss the report before buying?

    Yes, absolutely.
    Our team is available to help you make an informed decision. Whether you have questions about the report’s scope, methodology, customization options, or which license suits you best, we’re here to assist. Please reach out to us at sales@theinsightpartners.com, and one of our representatives will get in touch promptly.

    Will I get a billing invoice upon purchase?

    Yes, a billing invoice will be automatically generated and sent to your registered email upon successful completion of your purchase.
    If you need the invoice in a specific format or require additional details (such as company name, GST, or VAT information), feel free to contact us, and we’ll be happy to assist.

    Is there support available if I can’t access my report?

    Yes, certainly.
    If you encounter any difficulties accessing or receiving your report, our support team is ready to assist you. Simply reach out to us via email or live chat with your order information, and we’ll ensure the issue is resolved quickly so you can access your report without interruption.

    Our Clients

    • Labcorp Drug Development

    • Icon Plc

    • Cognizant Technology Solutions

    • Corporation

    • Ergomed Plc.

    • Capgemini

    • Genpact Limited

    • Accenture Plc.

    • Iqvia Holdings Inc.

    • International Business Machines Corporation

    • Bioclinica Inc.

    Sales Assistance
    US: +1-646-491-9876
    UK: +44-20-8125-4005
    Email: sales@theinsightpartners.com
    Chat with us
    DUNS Logo
    87-673-9708
    ISO Certified Logo
    ISO 9001:2015
    ISO Certified Logo